Riskpilot← Back to searchSign inGet full accessViljan Vård och Behandling AB
ABActiveOrg 5564997319Other residential care activities n.e.c. · NACE 8799Est. 199450-99 employees
Revenue 2024
SEK 48M
-26% vs 2023
EBITDA margin
-3.6%
-1% vs 2023
Equity ratio
62.2%
Financial strength
Net profit 2024
SEK 2,3M
| Revenue | SEK 48M | -26% |
| EBITDA | SEK -1,7M | -1% |
| Net profit | SEK 2,3M | — |
| Total assets | SEK 14,7M | -11% |
| Equity | SEK 9,2M | +33% |
| Employees | — | — |
Legal name
Viljan Vård och Behandling AB
Org number
5564997319
Legal form
Aktiebolag
NACE code
8799 · Other residential care activities n.e.c.
Founded
2 december 1994
Share capital
SEK 100 000
Employees
50-99
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas av en av ledamöterna i förening med Sandberg, Anna Maria Elisabeth Dessutom har verkställande direktören rätt att teckna firman beträffande löpande förvaltningsåtgärder
Company purpose
Bolaget ska bedriva hem för vård och boende, skolverksamhet samt idka därmed förenlig verksamhet.
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 82 240 | 72 612 | 59 873 | 64 923 | 48 045 |
| Staff expenses | — | — | — | — | — |
| EBITDA | 11 430 | 193 | −3 373 | −1 727 | −1 748 |
| Depreciation & amort. | −0 | −0 | −0 | −38 | −130 |
| EBIT | 11 430 | 193 | −3 373 | −1 765 | −1 878 |
| Net financials | −64 | 16 | −24 | 59 | −71 |
| Profit before tax | 8 530 | 140 | 0 | 0 | 2 912 |
| Tax | −1 872 | −42 | −0 | −0 | −639 |
| Net profit | 6 658 | 98 | 0 | 0 | 2 273 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 23 342 | 16 812 | 17 023 | 16 544 | 14 709 |
| Equity | 6 779 | 6 877 | 6 877 | 6 877 | 9 150 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 13 719 | 7 023 | 7 234 | 6 738 | 5 559 |
| Total debt | 13 719 | 7 023 | 7 234 | 6 738 | 5 559 |
EBITDA margin
-3.6%
This company
15.8%
Market median
-123% vs market
20202024
Equity ratio
62.2%
This company
38.2%
Market median
+63% vs market
20202024
Return on equity
24.8%
This company
18.4%
Market median
+35% vs market
20202024
Net profit margin
4.7%
This company
8.1%
Market median
-42% vs market
20202024
Asset turnover
3.27×
This company
1.12×
Market median
+192% vs market
20202024
Debt / equity
0.61×
This company
0.62×
Market median
+2% vs market
20202024
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
SM Chief Executive Officer | Chief Executive Officer | 2025 |
MV Chief Auditor | Chief Auditor | 2024 |
| Former (7) | ||
MC Chief Executive Officer | Chief Executive Officer | 2021 – 2021 |
LC Chief Executive Officer | Chief Executive Officer | 2023 – 2023 |
HN Chief Auditor | Chief Auditor | 2022 – 2022 |
AL Chief Auditor | Chief Auditor | 2022 – 2024 |
SP Chief Auditor | Chief Auditor | 2020 – 2022 |
EJ Chief Executive Officer | Chief Executive Officer | 2021 – 2025 |
AK Chief Executive Officer | Chief Executive Officer | 2022 – 2023 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2025 | |
| Chairman | 2025 | |
| Former (9) | ||
| Board of Directors | 2021 – 2024 | |
| Board of Directors | 2024 – 2025 | |
| Chairman | 2024 – 2025 | |
| Board of Directors | 2021 – 2024 | |
| Chairman | 2021 – 2024 | |
| Board of Directors | 2021 – 2022 | |
| Board of Directors | 2020 – 2021 | |
| Chairman | 2020 – 2021 | |
| Chairman | 2025 – 2025 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2025 | |
| Company | 100% | 100% | 0001 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Attendo Holding AB
Viljan Vård och Behandling AB Board members of Viljan Vård och Behandling AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Marie Cecilia Björkman | Chief Executive Officer | 0 companies |
| Lasse Camehagen | Chief Executive Officer | 0 companies |
| Hans Nicklas Renström | Chief Auditor | 0 companies |
| Anna Linnea Franke | Chief Auditor | 0 companies |
| Sven Patric Hofréus | Chief Auditor | 0 companies |
| Stina Mikaela Holmlund Kelly | Chief Executive Officer | 0 companies |
| Martin Viktor Bengtsson | Chief Auditor | 0 companies |
| Erik Johan Ludvig Gustafsson | Chief Executive Officer | 0 companies |
| Anna K Helena Söderqvist Lönnblad | Chief Executive Officer | 0 companies |
| Nina Ulrika Ekman Grönberg | Board of Directors | 0 companies |
| Sonja Malin Maria Mette Nanneson | Board of Directors | 0 companies |
| Nils Sven Patrik Högberg | Chairman | 0 companies |
| Åsa Maria Bondesson | Board of Directors | 0 companies |
| Maria Christina Andersson | Board of Directors | 0 companies |
| Nils Ola Klingenborg | Chairman | 0 companies |
| Markku Jalmari Onnela | Board of Directors | 0 companies |
| Mats Olof Egon Reimertz | Board of Directors | 0 companies |
| Rickard Weber | Chairman | 0 companies |
| Anna Maria Elisabeth Sandberg | Chairman | 0 companies |
| Carl Mikael Häägg | Chairman | 0 companies |